EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mucosal vaccination with hemagglutinin stalk provides broad protection against influenza virus subtypes in mice

Weizhong Li, Arunraj M Rajendrakumar, ZiZhen Miao, Bibek Dhakal, Bogdan M Domrachev, Tao Wang, Qiuqi Kan, Qiaofeng Wan, Hongquan Wan, Wenbin Tuo, Florian Krammer, Zhiping Ye und 1 weitere

Journal of Clinical Investigation · 16.11.2026 · 136 (22)

DOI: 10.1172/jci203675 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.11.2026. Verfasst von Weizhong Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, USA. Hauptthemen laut MEDLINE: Influenza Vaccines, Orthomyxoviridae Infections, Hemagglutinin Glycoproteins, Influenza Virus, Immunity, Mucosal. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, USDA NIFA A1181 Biosecurity grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza viruses continually evolve through antigenic drift and shift, spreading via respiratory droplets and aerosols. Developing a universal nasal vaccine is essential for preventing seasonal and pandemic infections by inducing long-lasting immunity in the respiratory tract. The neonatal Fc receptor (FcRn) transfers IgG Abs across the epithelial barrier. This study investigates whether the i.n. delivery of the conserved Stalk antigen of HA, utilizing the FcRn, can stimulate protective immune responses against various influenza virus subtypes. We engineered a monomeric IgG Fc fused to a modified HA Stalk in its prefusion form. Mice i.n. immunized with Stalk-Fc exhibited significant protection against infections from H1N1, H5N1, H6N2, and H9N2 compared with groups of control mice. The immunized mice produced long-lasting HA Stalk–specific IgA and IgG Abs in nasal washes, bronchoalveolar lavage, and blood, along with tissue-resident memory T cells in the lungs and long-lived plasma cells in the bone marrow. This led to notably lower viral replication in the nasal turbinate and lungs. The Stalk-specific Abs demonstrated strong cross-reactivity against different influenza subtypes through neutralization, Ab- or complement-dependent cellular cytotoxicity, or phagocytosis. These results indicate that FcRn efficiently transports HA Stalk-Fc across the respiratory epithelial barrier, supporting the development of a universal influenza nasal vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesOrthomyxoviridae InfectionsHemagglutinin Glycoproteins, Influenza VirusImmunity, MucosalAnimalsMiceReceptors, FcAntibodies, ViralFemaleMice, Inbred BALB CImmunoglobulin GHistocompatibility Antigens Class IVaccinationAdministration, Intranasal

Stichwörter der Autor:innen

ImmunologyInfectious diseaseInfluenzaVaccinesVirology

Substanzen

Influenza VaccinesReceptors, FcAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusFc receptor, neonatalImmunoglobulin GHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Division of Immunology, Virginia-Maryland College of Veterinary Medicine, University of Maryland, College Park, Maryland, USA.
  • Animal Parasitic Diseases Laboratory, Agricultural Research Service, United States Department of Agriculture, Beltsville, Maryland, USA.
  • Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Förderung

  • National Institute of Allergy and Infectious Diseases
  • USDA NIFA A1181 Biosecurity grant

Zitieren

APA

Li, W., Rajendrakumar, A. M., Miao, Z., Dhakal, B., Domrachev, B. M., Wang, T., Kan, Q., Wan, Q., Wan, H., Tuo, W., Krammer, F., Ye, Z., & Zhu, X. (2026). Mucosal vaccination with hemagglutinin stalk provides broad protection against influenza virus subtypes in mice. Journal of Clinical Investigation, 136(22). https://doi.org/10.1172/jci203675

Vancouver

Li W, Rajendrakumar AM, Miao Z, Dhakal B, Domrachev BM, Wang T, et al. Mucosal vaccination with hemagglutinin stalk provides broad protection against influenza virus subtypes in mice. Journal of Clinical Investigation. 2026;136(22). doi:10.1172/jci203675

BibTeX
@article{Li2026,
  author = {Li, Weizhong and Rajendrakumar, Arunraj M and Miao, ZiZhen and Dhakal, Bibek and Domrachev, Bogdan M and Wang, Tao and Kan, Qiuqi and Wan, Qiaofeng and Wan, Hongquan and Tuo, Wenbin and Krammer, Florian and Ye, Zhiping and Zhu, Xiaoping},
  title = {Mucosal vaccination with hemagglutinin stalk provides broad protection against influenza virus subtypes in mice},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {22},
  doi = {10.1172/jci203675}
}
Kostenlos starten →